Baraclude taken out from Seoul National University Hospital’s internal code list

A BMS Korea’s hepatitis treatment, Baraclude has finally been taken out from the internal code list of Seoul National University Hospital.

According to the industry concerned on the 21^st, one of the Seoul National University Hospital’s pharmaceutical distribution companies, which made a bid for a group of 44 products including Baraclude, were told to make an agreement with Bukwang Pharm’s Buk...